The much awaited results of the phase 1/2 Oxford COVID-19 vaccine trial is now published. As per the researches, they have got more success than what they have expected. The vaccine turns out to be safe, well-tolerated and immunogenic.
Richard Horton, chief editor of the famous magazine The Lancet gave information about it via a tweet.
Richard has earlier stern the media yesterday with his tweet regarding the corona trial result. After that, much speculation has been raised in the international community which was eager for the vaccine results.